Business Description
Serina Therapeutics Inc
NAICS : 541714
SIC : 2834
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.79 | |||||
Equity-to-Asset | -0.4 | |||||
Debt-to-Equity | -2.57 | |||||
Debt-to-EBITDA | -1.67 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 26.23 | |||||
9-Day RSI | 43.05 | |||||
14-Day RSI | 49.26 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.64 | |||||
Quick Ratio | 0.64 | |||||
Cash Ratio | 0.62 | |||||
Days Sales Outstanding | 0.73 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -454 | |||||
Net Margin % | -536.4 | |||||
FCF Margin % | -679.45 | |||||
ROA % | -67.7 | |||||
ROIC % | -40.39 | |||||
ROC (Joel Greenblatt) % | -581.71 | |||||
ROCE % | -281.67 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 22.73 | |||||
PS Ratio | 116.38 | |||||
EV-to-EBIT | -9.82 | |||||
EV-to-EBITDA | -9.9 | |||||
EV-to-Revenue | 131.19 | |||||
EV-to-FCF | -18.86 | |||||
Earnings Yield (Greenblatt) % | -10.18 | |||||
FCF Yield % | -5.8 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Serina Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.472 | ||
EPS (TTM) (€) | -2.836 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 49.26 | ||
14-Day ATR (€) | 0.434078 | ||
20-Day SMA (€) | 6.2805 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (€) | 3.06 - 11.3 | ||
Shares Outstanding (Mil) | 8.88 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Serina Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Serina Therapeutics Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Serina Therapeutics Inc Frequently Asked Questions
What is Serina Therapeutics Inc(FRA:2BO)'s stock price today?
When is next earnings date of Serina Therapeutics Inc(FRA:2BO)?
Does Serina Therapeutics Inc(FRA:2BO) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |